Scientists say vaccine temporarily brakes HIV
A team of Spanish researchers say they have developed a therapeutic vaccine that can temporarily brake growth of the HIV virus in infected patients.
HIV & AIDS
Jan 03, 2013 |
4.7 / 5 (3) |
3
In Ethiopia, HIV disclosure is low
In Ethiopia, where more than 1.2 million people are infected with HIV, disclosure of infection by patients is important in the fight against the disease. A new study led by a Brown sociology researcher investigates HIV-positive ...
HIV & AIDS
Jan 02, 2013 |
not rated yet |
0
Brazil to begin tracking numbers of HIV cases
(AP)—Brazilian health officials say doctors will be required to notify authorities of every HIV case in the nation.
HIV & AIDS
Dec 27, 2012 |
not rated yet |
0
HIV patients in care lose more years of life to smoking than to HIV infection
Among HIV patients receiving well-organized care with free access to antiretroviral therapy, those who smoke lose more years of life to smoking than to HIV, according to a Danish study published in Clinical Infectious Di ...
HIV & AIDS
Dec 19, 2012 |
not rated yet |
0
Despite cART, anal cancer risk still high for HIV-infected
(HealthDay)—For HIV-infected patients, despite combined antiretroviral treatment (cART), the risk of anal cancer is still much higher than in the general population, according to a study published in the ...
HIV & AIDS
Dec 13, 2012 |
not rated yet |
0
Atherosclerosis found in HIV children
Children with HIV have a 2.5 fold increased risk of atherosclerosis, according to research presented at EUROECHO and other Imaging Modalities 2012. Antiretroviral treatment, lipid lowering drugs and prevention with healthy ...
HIV & AIDS
Dec 05, 2012 |
not rated yet |
0
Antiretroviral treatment for HIV reduces food insecurity
Can treatment with modern anti-HIV drugs help fight hunger for HIV-infected patients in Africa? Starting antiretroviral therapy for HIV reduces "food insecurity" among patients in Uganda, suggests a study published online ...
HIV & AIDS
Dec 04, 2012 |
not rated yet |
0
Stigma for Central America's HIV-positive kids
Four-year-old Carlos, who makes a lengthy trip every two weeks with his teenage aunt to a special clinic in El Salvador's capital, has no notion of the cruel stigma that comes with his HIV diagnosis.
HIV & AIDS
Dec 02, 2012 |
not rated yet |
0
South Africa makes progress in HIV/AIDS fight
(AP)—In the early 90s when South Africa's Themba Lethu clinic could only treat HIV/AIDS patients for opportunistic diseases, many would come in on wheelchairs and keep coming to the health center until ...
HIV & AIDS
Dec 01, 2012 |
not rated yet |
0
AIDS: Chinese study raises flag over drugs-as-prevention hope
A Chinese study published on World AIDS Day on Saturday says drugs used to curb HIV in infected people also help protect their uninfected partner, but far less effectively than other research has found.
HIV & AIDS
Nov 30, 2012 |
4 / 5 (1) |
0
Caution still advised despite ever-improving HIV drugs
Combination therapies for AIDS are becoming increasingly effective, but they cannot protect against other sexually transmitted illnesses. It is unsafe for patients taking antiretroviral drugs to stop using ...
HIV & AIDS
Nov 30, 2012 |
not rated yet |
0
Studies target high rates of HIV medication errors among hospitalized patients
Research presented at IDWeek 2012 concludes that despite advances in electronic medical records, mistakes are still commonly made in the prescription of antiretroviral medications for hospitalized HIV-positive patients. At ...
HIV & AIDS
Oct 19, 2012 |
not rated yet |
0
No benefit from high-dose multivitamins seen for HIV patients receiving antiretroviral therapy
A new study by Harvard School of Public Health (HSPH) researchers suggests that, for HIV patients receiving highly active antiretroviral therapy (HAART) to treat HIV, there is no benefit from high- vs. standard-dose micronutrient ...
HIV & AIDS
Oct 16, 2012 |
5 / 5 (1) |
0
|
HIV status doesn't influence Hodgkin's lymphoma outcome
(HealthDay)—Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, ...
Cancer
Oct 11, 2012 |
not rated yet |
0
HIV drug shows efficacy in treating mouse models of HER2+ breast cancer
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published October 5 in the Journal of th ...
Cancer
Oct 06, 2012 |
not rated yet |
0
|
